Acute myeloid leukemia with multilineage dysplasia in children

International Journal of Hematology

Volumn 86, Issue 4, 2007, Pages 358-363

  Adachi, Souichi ^a   Manabe, Atsushi ^b   Imaizumi, Masue ^c   Taga, Takashi ^d   Tawa, Akio ^e   Tsurusawa, Masahito ^f   Kikuchi, Akira ^g   Masunaga, Atsuko ^h   Tsuchida, Masahiro ⁱ   Nakahata, Tatsutoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c MIYAGI CHILDREN S HOSPITAL   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e OSAKA NATIONAL HOSPITAL   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

^g SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^h SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

ⁱ Ibaraki Children's Hospital   (Japan)

Author keywords

AML with multilineage dysplasia; Children; Retrospective analysis

Indexed keywords

BUSULFAN; CHROMIUM; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; VINCRISTINE;

ACUTE MYELOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA WITH MULTILINEAGE DYSPLASIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CANCER THERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DYSPLASIA; FEMALE; GRAFT REJECTION; HUMAN; MALE; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION; ACUTE GRANULOCYTIC LEUKEMIA; CELL LINEAGE; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE;

EID: 40449134868     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.07025     Document Type: Article

References (17)

1. F Brito-Babapulle D Catovsky DA Galton 1987 Clinical and laboratory features of de novo acute myeloid leukemia with trilineage myelodysplasia Br J Haematol 66 445 450
2. B Gahn D Haase M Unterhalt 1996 De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance Leukemia 10 946 951
3. JE Goasguen T Matsuo C Cox JM Bennett 1992 Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival Leukemia 6 520 525
4. K Kuriyama M Tomonaga T Matsuo 1994 Poor response to intensive chemotherapy in de novo acute myeloid leukemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG) Br J Haematol 86 767 773
5. Y Miyazaki K Kuriyama S Miyawaki 2003 Japan Adult Leukaemia Study Group. Cytogenetic heterogeneity of acute myeloid leukemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study Br J Haematol 120 56 62
6. J Taguchi Y Miyazaki S Yoshida 2000 Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD) Leukemia 14 1861 1866
7. H Sasaki A Manabe S Kojima 2001 Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan Leukemia 15 1713 1720
8. I Tsukimoto A Tawa R Hanada 2005 Excellent outcome of risk stratified treatment for childhood acute myeloid leukemia-AML 99 trial: for the Japanese Childhood AML Cooperative Study Group Blood 106 261a 261a
9. D Grimwade H Walker F Oliver 1998 The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 2322 2333
10. Brunning RD, Matutes E, Harris NL, et al. Acute myeloid leukemia with multilineage dysplasia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
11. MH Estienne P Fenaux C Preudhomme 1990 Prognostic value of dysmyelopoietic features in de novo acute myeloid leukemia: a report on 132 patients Clin Lab Haematol 12 57 65
12. KK Ballen DG Gilliland LA Kalish LN Shulman 1994 Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival Cancer 73 314 321
13. G Meckenstock C Aul B Hildebrandt 1998 Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance Leuk Lymphoma 29 523 531
14. C Kahl A Florschütz G Müller 1997 Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia Ann Hematol 75 91 94
15. K Kuriyama M Tomonaga T Kobayashi 2001 Morphological diagnosis of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: central review Int J Hematol 73 93 99
16. T Haferlach C Schoch H Löffer 2003 Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies J Clin Oncol 21 256 265
17. D Tomizawa K Tabuchi A Kinoshita 2007 Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group Pediatr Blood Cancer 49 127 132